세계의 마이크로카테터 시장 규모는 예측 기간인 2024-2031년에 5.55%의 연평균 복합 성장률(CAGR)로 확대되었으며, 2023년 9억 939만 달러에서 2031년에는 14억 93만 달러로 예측되고 있습니다. 세계의 마이크로카테터 시장은 의료기기 시장의 중요한 일부입니다.
마이크로카테터는 주로 낮은 침습 수술로 이용되며 약과 장치를 투여할 수 있는 얇은 소형 직경의 튜브로 특징지어집니다. 경피 관상 동맥 및 신경혈관 처리에 자주 사용됩니다. 스템형일 수도 있지만, 선주문 시 일정한 형태로 제조될 수도 있습니다. 마이크로카테터는 진단 및 치료 목적으로 가이드와이어 및 기타 인터벤션 기구의 삽입이나 교환에 사용할 수 있습니다. 친수성 코팅은 복잡한 혈관계를 통과하는 네비게이션입니다. 코일 피치는 유연성과 근위에 밀어 넣기 용이성을 촉진합니다. 관상 동맥 구조, 다지 병변, 왼쪽 주간 협착 등은 모두 노인 환자에게 많이 보입니다.
이 보고서는 세계의 마이크로카테터 시장을 조사했으며, 시장 개요와 함께 제품별, 용도별, 디자인별, 최종 사용자, 지역별 동향, 시장 진출기업 프로파일 등의 정보를 제공합니다.
Global microcatheters market is projected to witness a CAGR of 5.55% during the forecast period 2024-2031, growing from USD 909.39 million in 2023 to USD 1400.93 million in 2031. The global microcatheters market is an important part of the medical device market. The market is being driven by factors such as the increasing prevalence of chronic diseases, rising adoption of minimally invasive surgeries, and technological innovations.
Microcatheters are mostly utilized in minimally invasive surgeries and are characterized as thin-walled, small-diameter tubes via which medications and devices can be administered. These tiny catheters are frequently used for percutaneous coronary and neurovascular procedures because they are perfect for guiding these catheters into arteries. Microcatheters can be stem-shaped but are also manufactured in a certain shape during preorder. Steerable microcatheters have been employed in cardiac applications, including balloon delivery, to increase vascular flow in elderly patients. Microcatheters can be used to insert and replace guidewires and other interventional devices for diagnostic and therapeutic purposes. Most microcatheters contain a lubricious coating and an integrated steerable or angled tip to facilitate penetration and delivery. The hydrophilic covering improves navigation through convoluted vasculatures, while the coil pitch promotes flexibility and proximal pushability. Microcatheters are also widely utilized in percutaneous coronary intervention (PCI). Calcified and ostial lesions, tortuous coronary anatomy, multivessel disease, and left main stem stenosis are all more common in geriatric patients.
In November 2023, Transit Scientific Inc., a Utah-based medical device company, received FDA approval for its next-generation microcatheter, the XO Cath. This innovative device is designed to accurately deliver embolic agents, marking a significant advancement in microcatheter technology. The XO Cath microcatheter is engineered to offer unprecedented levels of trackability, torque responsiveness, and embolic compatibility, thereby enhancing the precision and effectiveness of therapy administration.
Increasing Prevalence of Chronic Diseases Drive Market Growth
The rising prevalence of cardiovascular and neurovascular diseases is a key contributor to the growing need for microcatheters. Chronic cardiac disorders such as myocardial infarction, angina, atherosclerosis, and ischemic stroke are on the rise and frequently necessitate minimally invasive procedures in which microcatheters play an important role. Neurovascular illnesses such as brain aneurysms and blood clots also play a key role in the need for these tiny, flexible catheters used to reach distant anatomy and administer therapies. The aging population is particularly sensitive to these diseases, which fuels the demand for better microcatheter technologies to provide precise diagnosis and treatment with less patient harm. As per a report from the British Heart Foundation, around 200 million people have coronary heart disease globally, out of which 57.89% of the patients were male and 42.11% were female.
Rising Adoption of Minimally Invasive Surgeries Positively Impact Market Growth
The growing global demand for microcatheters is driven mostly by the increased adoption of minimally invasive surgical procedures. Minimally invasive surgeries, which use small incisions and enhanced imaging guidance, are becoming increasingly common in several medical areas, including cardiology, neurovascular, and cancer. Microcatheters are crucial in facilitating these treatments because they allow access to distant areas of the body, distribute therapeutic medicines, and facilitate the use of embolic materials. According to the American Society of Plastic Surgeons, in 2022, 26.2 million surgical and minimally invasive cosmetic and reconstructive operations were carried out in the United States. Since 2019, the number of surgeries performed has increased by 19%.
Cardiovascular Segment Holds the Highest Share in the Global Microcatheters Market
Microcatheters are often used in cardiovascular treatments because of their capacity to perform complex interventions and navigate complicated arterial anatomy. They are very effective in percutaneous coronary interventions (PCI) to treat difficult lesions such as bifurcations, ostial lesions, calcified arteries, and chronic total occlusions (CTOs). Microcatheters support guidewires, allow the exchange of guidewires, and help administer therapeutic devices like balloons and stents. They are available in a variety of configurations, including single-lumen, dual-lumen, steerable, and angled tip designs, allowing operators to choose the most suitable microcatheter depending on anatomical and lesion features. The introduction of microcatheters has broadened the scope of percutaneous coronary intervention by making it possible to treat complicated lesions that were previously considered high-risk or inappropriate for treatment.
Single-Lumen Microcatheters Dominate the Market
Single-lumen microcatheters are the most widely used microcatheters globally due to their simplicity and effectiveness in various interventional procedures, particularly in cardiology. They account for a significant share of the global microcatheters market, primarily because they provide reliable support for guidewires, allowing for easy navigation through complex vascular structures. Their design facilitates reshaping and wire exchanges without displacing the catheter from the vessel entry, which is crucial during delicate procedures. In July 2024, Transit Scientific LLC reported the successful clinical deployment of the XO Cath, an embolic delivery single-lumen microcatheter suited for interventional procedures. A patient with prostatic artery embolization (PAE) was treated with a single-lumen embolic delivery microcatheter, which had a considerable arterial blockage and demonstrated the microcatheter's capabilities, notably its mobility while passing through the arteries.
Future Market Scenario (2024-2031F)
Integration With Medical Imaging Technologies: Microcatheters will be integrated with advanced imaging technologies such as intravascular ultrasound, optical coherence tomography, and magnetic resonance imaging. This integration will provide real-time visualization and guidance during procedures, improving the accuracy and efficiency of minimally invasive surgeries.
Introduction of New Materials: The microcatheters market is expected to see significant advancements in material science, leading to the development of more flexible, durable, and biocompatible materials.
Development of Smart Catheters: The market will likely witness the development of smart catheters equipped with sensors, actuators, and microprocessors. These smart catheters will be capable of monitoring and adjusting their performance in real-time, enhancing the precision and safety of procedures.
New Applications: Microcatheters are expected to find new applications in areas such as regenerative medicine, gene therapy, and targeted drug delivery. Developing microcatheters with specialized coatings and delivery systems will enable the precise delivery of therapeutic agents to specific tissues and organs, opening new avenues for treatment and research.
Key Players Landscape and Outlook
The microcatheter market is growing faster, fostering several local and global players. The market is quite stimulated with new regulatory approvals and product launches. The market has witnessed significant deals, including acquisitions, regulatory approvals, and product launches. For instance, in March 2024, the Food and Drug Administration (FDA) approved Emblox Inc.'s Soldier High Flow Microcatheter. The microcatheter improves flow rates while using the same ultra-thin wall (UTW) technology and superior design. The UTW technology allows for a smaller outer diameter while keeping the highest interior lumen count, thereby increasing the flow rate twofold.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.